Previous Close | 44.09 |
1-Year Change | -22.17% |
6-Months Change | 1.45% |
3-Months Change | -6.65% |
Moving Avg (50d) | 48.356 |
Moving Avg (200d) | 44.796 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 2.11B |
Beta (3-Years) | 0.55 |
Revenue Growth (ttm) | 24.02% |
Net Profit Margin (ttm) | 22.5% |
Return On Assets (ttm) | 8.76% |
EPS (ttm) | 2.55 |
PE Ratio (ttm) | 17.29 |
Dividend Yield | % |
Asset Description: | Amphastar Pharmaceuticals, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-07 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
44.972 | 46.295 | 47.176 | 48.499 | 50.704 | 52.908 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.